Penn Medicine researchers take step toward personalized CAR T-like treatment for rare form of autoimmune disease
CAR T cell therapy can be reworked to treat a form of the autoimmune disease myasthenia gravis according to a preclinical study from the Perelman School of Medicine.
FULL STORY AT Penn Medicine News →